Maximizing the Benefits of a Type D Meeting

Time: 11:15 am
day: Day 2 REGULATORY AM

Details:

• Understanding the scope, associated timelines, and practicalities of FDA Type D meetings and any follow-up opportunities
• Reflections from engaging in a Type D meeting and advice for others seeking to engage
• How do these meetings fit into an overall development plan?

Speakers:

Darshna Patel Darshna Patel, VP Regulatory Affairs at Neurocrine Biosciences, has been in industry ~34 years working in early to late drug development across various different therapeutic Read more